Headlands Technologies’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$30.3K	Buy	+1,055	New	+$30.3K	﹤0.01%	865
2025 Q1	–	Sell	-1,022	Closed	-$52.3K	–	1208
2024 Q4	$52.3K	Buy	+1,022	New	+$52.3K	0.01%	808